MURPHY JOHN RAYMOND 13D and 13G filings for Cadrenal Therapeutics, Inc. Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 5:18 pm Purchase | 2023-12-31 | 13G | Cadrenal Therapeutics, Inc. Common Stock CVKD | MURPHY JOHN RAYMOND | 47,653 5.490% | 8,000 (+20.18%) | Filing |
| 2023-03-27 06:09 am Purchase | 2023-03-16 | 13G | Cadrenal Therapeutics, Inc. Common Stock CVKD | MURPHY JOHN RAYMOND | 39,653 5.110% | 39,653 (New Position) | Filing |